Infectives Vaccine Partnering Terms and AgreementsCurrent Partnering
November 1, 2012
720 Pages - SKU: WWV4906634
Additional InformationReport scope
Infectives Vaccine Partnering Agreements is intended to provide the reader with an in-depth understanding and access to infectives vaccine trends and structure of deals entered into by leading companies worldwide.
Infectives Vaccine Partnering Agreements includes:
Trends in infectives vaccine dealmaking in the biopharma industry since 2007
Analysis of infectives vaccine deal structure
Access to headline, upfront, milestone and royalty data
Access to over 600 cancer vaccine deal records
The leading infectives vaccine deals by value since 2007
Includes adjuvant and drug delivery deals and alliances since 2007
In Infectives Vaccine Partnering Agreements, the available deals are listed by:
Stage of development at signing
Deal component type
Specific oncology therapy target
Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
The Infectives Vaccine Partnering Agreements report provides comprehensive access to available deals and contract documents for over 600 infectives vaccine deals. Analyzing actual contract agreements allows assessment of the following:
What are the precise rights granted or optioned?
What is actually granted by the agreement to the partner company?
What exclusivity is granted?
What is the payment structure for the deal?
How aresalesand payments audited?
What is the deal term?
How are the key terms of the agreement defined?
How are IPRs handled and owned?
Who is responsible for commercialization?
Who is responsible for development, supply, and manufacture?
How is confidentiality and publication managed?
How are disputes to be resolved?
Under what conditions can the deal be terminated?
What happens when there is a change of ownership?
What sublicensing and subcontracting provisions have been agreed?
Which boilerplate clauses does the company insist upon?
Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
Which jurisdiction does the company insist upon for agreement law?
We can help you find what you need. Call us or write us:
Need help in your search?
Pandemic Vaccines Reports
- Global Vaccine Market Forecast to 2017
- Seasonal Influenza Vaccine Market in Asia-Pacific to 2018 - Positive Impact of Government Support Offset by Limited Production Capacity, High Investment and Strict Regulations as Barriers to New Entrants
- Forecast: Pneumococcal Vaccines
- PharmaPoint: Seasonal Influenza Vaccines - Current and Future Players
- EpiCast Report: Seasonal Influenza Vaccines Epidemiology Forecast to 2022